High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt.
作者信息
Soliman Amr S, Banerjee Mousumi, Lo An-Chi, Ismail Kadry, Hablas Ahmed, Seifeldin Ibrahim A, Ramadan Mohamed, Omar Hoda G, Fokuda Aya, Harford Joe B, Merajver Sofia D
出版信息
Breast J. 2009 Jul-Aug;15(4):432-4. doi: 10.1111/j.1524-4741.2009.00755.x.
Abstract
摘要
相似文献
1
High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt.埃及盖勒尤卜省基于人群的癌症登记处中炎性乳腺癌的比例较高。
Breast J. 2009 Jul-Aug;15(4):432-4. doi: 10.1111/j.1524-4741.2009.00755.x.
2
Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.2004 - 2008年，埃及盖勒尤比省基于人群的登记处与美国监测、流行病学和最终结果计划中按诊断年龄划分的乳腺癌情况对比
Biomed Res Int. 2015;2015:381574. doi: 10.1155/2015/381574. Epub 2015 Oct 1.
3
Urban-rural differences in breast cancer incidence in Egypt (1999-2006).埃及城乡乳腺癌发病率的差异（1999-2006 年）。
Breast. 2010 Oct;19(5):417-23. doi: 10.1016/j.breast.2010.04.005. Epub 2010 May 8.
4
Measuring the effect of improvement in methodological techniques on data collection in the Gharbiah population-based cancer registry in Egypt: Implications for other Low- and Middle-Income Countries.评估方法技术改进对埃及盖勒尤卜省基于人群的癌症登记处数据收集的影响：对其他低收入和中等收入国家的启示。
Cancer Epidemiol. 2015 Dec;39(6):1010-4. doi: 10.1016/j.canep.2015.11.001. Epub 2015 Nov 18.
5
Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt.埃及 6 年间不同激素受体状态乳腺癌发病率的城乡差异。
Breast Cancer Res Treat. 2010 Feb;120(1):149-60. doi: 10.1007/s10549-009-0427-9. Epub 2009 Jun 23.
6
Changing Incidence of Uterine Cancer in Rural Egypt: Possible Impact of Nutritional and Epidemiologic Transitions.埃及农村子宫癌发病率的变化：营养与流行病学转变的可能影响
J Glob Oncol. 2019 Jul;5:1-7. doi: 10.1200/JGO.18.00255.
7
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.炎性乳腺癌的分子流行病学特征：埃及与美国患者的比较
Breast Cancer Res Treat. 2008 Nov;112(1):141-7. doi: 10.1007/s10549-007-9833-z. Epub 2007 Dec 4.
8
An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades.对印度孟买及其他地区过去二十年乳腺癌发病率上升情况及趋势的流行病学评估。
Asian Pac J Cancer Prev. 2003 Jan-Mar;4(1):51-6.
9
Profile of familial breast cancer in Alexandria, Egypt.埃及亚历山大市家族性乳腺癌概况
Anticancer Res. 2001 Jul-Aug;21(4B):3011-4.
10
Urban-rural differences of gynaecological malignancies in Egypt (1999-2002).埃及城乡地区妇科恶性肿瘤发病差异（1999-2002 年）。
BJOG. 2010 Feb;117(3):348-55. doi: 10.1111/j.1471-0528.2009.02447.x. Epub 2009 Dec 16.
引用本文的文献
1
Characterization of mammographic markers of inflammatory breast cancer (IBC).炎性乳腺癌（IBC）的乳腺钼靶标记物特征
Phys Med. 2025 Jan;129:104870. doi: 10.1016/j.ejmp.2024.104870. Epub 2024 Dec 9.
2
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy.新辅助全身治疗炎性乳腺癌的治疗反应、肿瘤浸润淋巴细胞与临床结局
Cancer Res Commun. 2024 Jan 24;4(1):186-199. doi: 10.1158/2767-9764.CRC-23-0285.
3
Tailoring Treatment for Patients with Inflammatory Breast Cancer.为炎性乳腺癌患者制定治疗方案。
Curr Treat Options Oncol. 2023 Jun;24(6):580-593. doi: 10.1007/s11864-023-01077-0. Epub 2023 Apr 12.
4
Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes.针对炎性乳腺癌的主动免疫治疗方法可能改善患者预后。
Cells. 2022 Sep 13;11(18):2850. doi: 10.3390/cells11182850.
5
Inflammatory Breast Cancer: The Secretome of HCMV Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers.炎性乳腺癌：人巨细胞病毒肿瘤相关巨噬细胞的分泌组增强增殖、侵袭、集落形成及癌症干细胞标志物的表达。
Front Oncol. 2022 Jun 30;12:899622. doi: 10.3389/fonc.2022.899622. eCollection 2022.
6
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.CD20+ B 细胞和 PD-L1+ 免疫细胞对病理完全缓解和结局的差异影响：炎症性乳腺癌和局部晚期乳腺癌患者的比较。
Breast Cancer Res Treat. 2021 Dec;190(3):477-489. doi: 10.1007/s10549-021-06391-5. Epub 2021 Sep 20.
7
Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics.炎性乳腺癌患者生存分析与临床及组织病理学特征的关系
Cancer Manag Res. 2020 Dec 3;12:12447-12455. doi: 10.2147/CMAR.S278795. eCollection 2020.
8
Evaluating the incidence of inflammatory breast cancer using population- and hospital-based cancer registries in Casablanca, Morocco.在摩洛哥卡萨布兰卡，利用基于人群和医院的癌症登记系统评估炎性乳腺癌的发病率。
Breast Dis. 2019;38(2):39-45. doi: 10.3233/BD-180357.
9
Inflammatory Breast Cancer: A Literature Review.炎性乳腺癌：文献综述
World J Oncol. 2018 Nov;9(5-6):129-135. doi: 10.14740/wjon1161. Epub 2018 Nov 23.
10
Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).摩洛哥患者炎性乳腺癌的预后：来自国家肿瘤学研究所（INO）的 219 例病例的临床、分子和病理特征。
BMC Cancer. 2018 Jul 5;18(1):713. doi: 10.1186/s12885-018-4634-9.
本文引用的文献
1
Epidemiology of inflammatory breast cancer (IBC).炎性乳腺癌（IBC）的流行病学
Breast Dis. 2005;22:9-23. doi: 10.3233/bd-2006-22103.
2
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.炎性乳腺癌发病率及生存率趋势：美国国立癌症研究所的监测、流行病学与最终结果计划
J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172.
Zotero 插件